Journal of
Infectious Diseases and Immunity

  • Abbreviation: J. Infect. Dis. Immun.
  • Language: English
  • ISSN: 2141-2375
  • DOI: 10.5897/JIDI
  • Start Year: 2009
  • Published Articles: 87

Review

Ebola and its yet unproven therapeutic regimens

Saganuwan Alhaji Saganuwan
  • Saganuwan Alhaji Saganuwan
  • Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, University of Agriculture, P. M. B. 2373, Makurdi, Benue State, Nigeria.
  • Google Scholar


  •  Received: 16 November 2019
  •  Accepted: 14 April 2020
  •  Published: 31 May 2020

References

Akwafuo S, Guo S, Nikler A (2018). Epidemiological Modelling of vaccination and reduced funeral rates interventions on the production number, of Ebola virus disease in West Africa. Journal of Infectious Diseases Medicine and Microbiology 2(3):7-11.

 

ASM (2014). Ebola, Marbug viruses edit genetic material during infection. American Society for Microbiology, Public Release 4 Nov.

 

Bard EM (2015). Ebola virus.Clear and present danger. Journal of Clinical Microbiology 53(1):4-8.
Crossref

 

Bell A, Lewandowki K, Nuers R, Wooldridge D, Aarons E, Simpson A, Vipond R, Jacobs N, Gharbia S, Zambon M (2015). Genome sequence analysis of Ebola virus in clinical samples from the British healthcare worker, August 2014 to 2015. European Surveillance 20(20):1-5.
Crossref

 

Bixler SL, Duplantier AJ, Bavari S (2017).Discovering drugs for the treatment of Ebola virus. Current Treatment Opinions in Infectious Diseases 9(3):299-317.
Crossref

 

Broadhurst MJ, Brooks TJG, Pollock NR (2016). Diagnosis of ebola virus disease.Past, present and future. Clinical Microbiology Review 29(4):773-973.
Crossref

 

Butler D (2018). WHO says Africa's latest Ebola outbreak is not an international emergency. Nature 513:13-14.
Crossref

 

Cox DBT, Platt RJ, Zhang F (2015).Therapeutic genome editing: prospects and challenges. Nature Medicine 21(2):121-131.
Crossref

 

Cross RW, Mire CE, FEldmann H, Geisbert TW (2018). Post-exposure treatments for Ebola and Marburg virus infection. Nature Review and Drug Discovery 17(6):413-434.
Crossref

 

De la Vega MA, Steon D, Kobinger GP (2015). Ebola virus evolution: past and present. Plos Pathology 11(11):1-10.
Crossref

 

Dellicomr S, Baele G, Dudas G, Faria NR, Pybus OG, Suchard MA, Ranbaut A, Lamey P (2018). Phylodynamic assessment of intervention strategies for the West African ebola virus outbreak. Nature Communication 9(1):1-9.
Crossref

 

Dunning J, Sahr F, Rojek A, Gannon F, Carson G, Idriss B, Massaquol T, Gandi R, Joseph S, Osman HK, Brooks TJG, Simpson AJH, Goodfellow I, Thorne L, Arias A, Merson L, Castle L, Howell-Jones R, Parinaz-Solis R, Hope-Gill B, Ferri M, Grove J, Kowalski M, Stepniewska K, Lang T, Whitehead J, Olliaro P, Samai M, Horby PW (2016). Experimental treatment of Ebola virus disease with TKM-130803: a single arm phase 2 clinical trial. Plos Medicine 13(4):e1001997.
Crossref

 

Feldmann H, Geisbert TW (2011). Ebola hemorrhagic fever. Seminar 377:849-862.
Crossref

 

Formenty P (2018). Ebola virus disease. In: Emerging Infectious Disease, pp. 121-134.
Crossref

 

Geoghegan JL, Holmes ET (2018). The phytogenomic of evolving virus vitulence. Nature Review Genetics 19:756-769.
Crossref

 

Goldstein T, Anthony SJ, Gbakima A, Bird BH, Bangura J, Tremeau-Bravad A, Beleganhali MN, Wells HL, Dhanota JK, Liang E, Grodus M, Jangra RK, De Jesus VA, Lasso G, Smith BR, Janibai A, Kamaia BO, Kamara S, Bangura W, Monagin C, Shapira S, Johnson CK, Haque A, Hober D, Blondiaux J (2015). Addressing therapeutic options for Ebola virus infection in current and future outbreaks. Antimicrobial Agents Chemotherapy 59(10).
Crossref

 

Hampton T (2014).largest ever outbreak of Ebola virus disease thrusts experimental therapies, vaccines into spot light. Journal of American Medical Association 312(10):987-989.
Crossref

 

Haque A, Hober D, Blondlaux J (2015). Addressing therapeutic options for Ebola virus infection current and future outbreak. Antimicrobial Agents Chemotherapy 59(10):5892-5902.
Crossref

 

Hayden FG, Friede M, Bausch DG (2017). Experimental therapies for Ebola virus disease: what have we learnt? Journal of Infectious Diseases 215(2):167-170.
Crossref

 

Janus BM, Van Dyk N, Zhao X, Howel KA, Soto C, Aman MJ, Lit, Fuerst TR, Ofek G (2018). Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion gap. Nature Communication 9(1):1-12.
Crossref

 

Jun SR, Leuze MR, Nookaew I, Uberbacher EC, Land N, Zhang Q, Wanchai V, Chai J, Nielsen N, Trolle T, Lund O, Buzard GS, Pedersa, TD, Wassenaar TM, Ussery DW (2015).Ebola virus comparative genomics. EEMS Microbiology Review 39:764-778.
Crossref

 

Kadanali A, Karazog G (2015). An overview of ebola virus disease. NCL 2(1):81-86.

 

Kondratowicz AS, Maury WJ (2012). Ebolavirus: a brief review of novel therapeutic targets. Future Microbiology 7(1):1-4.
Crossref

 

Lamplard KB, Valiguette L (2014). Ebola virus disease. Canadian Journal of infectious Diseases Medicine and Microbiology 25(3):128-129.
Crossref

 

Lanini S, Portela G, Vairo F, Kobinger GP, Pensenti A. Langer M, Kabia S, Bogiati G, Amone J, Fang LQ, Tang T, Jiang JF, Yao HN, Kargbo D, Li XL, Jian S, BG, Kargbo B, Tong TG, Wang YW, Liu K, Kamara A, Dafae F, Kanu A, Jiang RR, Sun T Sun RX, Chen WJ, Ma MJ, Dean NE, Thomas H, LonginiJr IM, Hallirap ME, Cao WC (2016). Transmission dynamics of Ebola virus disease and intervention effectiveness on Sierra Leone. PNAS 113(16):448-4493.
Crossref

 

Liu SQ, EngCl, Tuan CM, Raynev S, Zhang B (2015).Identifying the pattern of molecular evolution for Zaire Ebola virus in the 2014 outbreak in West Africa. Infection, Genetics and Evolution 32:51-59.
Crossref

 

Maxmen A (2018a). Experimental ebola drugs face tough test in war zone. Nature 561(7721):14-15.
Crossref

 

Maxmen A (2018b) Latest outbreak. Nature 560(7718):289-290.
Crossref

 

Maxmen A (2018c). Ebola detectives race to identify hidden sources of infection as outbreak spreads. Nature 564(7735):174-175.
Crossref

 

Michalek P, Krejcova L, Adam V, Kizek R (2015). Epidemiology and pathogenesis of Ebola viruses. Journal of Metal Nanotechnology 1:48-52.

 

Rid A, Emmanuel JE (2014). Clinical considerations of experimental intervention in the Ebola outbreak. Lancet 384(9957):1896-1899.
Crossref

 

Saganuwan SA, Onyeyili PA (2012). Haematonic and plasma expander effects of aqueous extract of Abrusprecatorius leaf in Musmusculus. Comparative Clinical Pathology 21(6):1249-1255.
Crossref

 

Saganuwan SA, Onyeyili PA, Etuk EU (2014). Immunomodulatory potential of aqueous leaf extract of Abrusprecatorius in mice. Journal of Haematology Research 1(2):54-62.
Crossref

 

Saganuwan SA (2017). Functional chemical groups that may likely become a source for the synthesis of novel central nervous system (cns) acting drugs. Central Nervous System Agents in Medicinal Chemistry 17 (3):178-186.
Crossref

 

Sanchez A, Kiley NP, Holloway BP, McCormick JB, Aupevin DD (1989). The nucleoprotein gene of ebola virus: Cloning, sequencing, and in vitro expression 170(1):81-91.
Crossref

 

Sugita T, Matsunami H, Kawaoka T Noda T, Wolf M (2018). Cryo-EM structure of the ebola virus nucleoprotein- RNA, complex at 3-6 A resolution. Nature 653(7729):137-140.
Crossref

 

Sullivan N, Tang, ZT, Nabel GJ (2003). Ebola virus pathogenesis: Implications for vaccines and therapies. Journal of Virology 77(3):9733-9737.
Crossref

 

Swetha RG, Ramaiah S, Anbarabu A, Sekar K (2016). Ebola virus database: gene and protein information resource for Ebolavirus. Advance Bioinformatics, pp. 1-4.
Crossref

 

Urbanowicz RA, McClere CP, Sakuntabhai A, Shall AA, Kobinger G, Muller MA, Holmes EC, Rey FA, Simon-loriere E, Ball JK (2016). Human adaptation of Ebola virus during the West African outbreak. Cell 167(4):1079-1087.
Crossref

 

Van Puyvelde S, Argimon S (2018). Sequencing in the time of ebola. Nature Review Microbiology 17(1):5-5.
Crossref

 

WHO (2014).Laboratory diagnosis of Ebola virus disease. Interim Guideline World Health Organization, 19 Sept. 1-4.

 

WHO (2017).Emergencies preparedness, response.World Health Organization.